$10.55 Million in Sales Expected for ...

$10.55 Million in Sales Expected for Theravance Biopharma Inc (TBPH) This Quarter

Equities research analysts expect that Theravance Biopharma Inc will post $10.55 million in sales for the current fiscal quarter, Zacks reports. Three analysts have made estimates for Theravance Biopharma's earnings, with the highest sales estimate coming in at $12.50 million and the lowest estimate coming in at $8.64 million.

Start the conversation, or Read more at AmericanBankingNews.com.

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.